Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
Illumina's Bid to Beat Cancer with DNA Tests
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
₹0.00 for first 30 days
Season's Savings
₹5/month for first 3 months
Offer ends on 28 December, 2026.
Only ₹5/month for first 3 months.
Get 1 credit per month to use on any title of your choice.
Listen to anything from the Plus Catalogue—thousands of audiobooks, podcasts, and Audible Originals.
₹199/month after first 3 months. Cancel anytime. Renews automatically. Offer ends 28 December, 2026.
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199.00 per month after 30-day trial. Cancel anytime.
Buy Now for ₹165.26
-
Narrated by:
-
Todd Mundt
-
Written by:
-
Antonio Regalado
About this listen
The world’s largest DNA sequencing company says it will form a new company to develop blood tests that cost $1,000 or less and can detect many types of cancer before symptoms arise. Illumina, based in San Diego, said its blood tests should reach the market by 2019, and would be offered through doctors’ offices or possibly a network of testing centers.
©2016 Massachusetts Institute of Technology (P)2016 Massachusetts Institute of Technology
adbl_web_anon_alc_button_suppression_t1
No reviews yet